CDT
CDT EquityFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
Composite grade F from latest DB weights. Momentum 4.4 / Value 58.8
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +17.6.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
4
Value
59
Sentiment
N/A
Setup hits (3d)
— · Net —
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net —
Why
Momentum4 · Δ7d -
Value59 · Δ7d +17.6
SentimentN/A · Δ7d -
So what
Weak posture. Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
4
40% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
59
60% active weight
Current posture
7d trendImproving
Δ7d
+17.6
Δ21d
+17.7
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 4.4 / Value 58.8
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$152K
Beta
1.77
Shares Out
4.86M
P/E (TTM) · Derived
-0.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.00
Rev YoY
-
EPS YoY
-95.6%
Gross Margin
-
Op Margin
-
Net Debt
-$734K
Current Ratio
0.34
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology